Journal of Oral Pathology and Medicine · 2021 · 29 citations · 24 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyNeoplasiaCancer Stem Cell BiologyCancer Stem CellsMalignant NeoplasmsMalignant Salivary Gland TumorsSalivary Gland CancerSalivary Gland MalignanciesCancer Stem-like CellsHistone AcetylationHistone Acetylation ProfilingHistone-lysine AcetylationOral Mucoepidermoid CarcinomaSalivary Gland Stem CellsTumor Growth MonitoringTumor Growth Rate
AIM: To evaluate the potential use of Cephaeline as a therapeutic strategy to manage mucoepidermoid carcinomas (MEC) of the salivary glands. MATERIAL AND METHODS: UM-HMC-1, UM-HMC-2, and UM-HMC-3A MEC cell lines were used to establish the effects of Cephaeline over tumor viability determined by MTT assay. In vitro wound healing scratch assays were performed to address cellular migration while immunofluorescence staining for histone H3 lysine 9 (H3k9ac) was used to identify the acetylation status of tumor cells upon Cephaeline administration. The presence of cancer stem cells was evaluated by the identification of ALDH enzymatic activity by flow cytometry and through functional assays using in vitro tumorsphere formation. RESULTS: A single administration of Cephaeline resulted in reduced viability of MEC cells along with the halt on tumor growth and cellular migration potential. Administration of Cephaeline resulted in chromatin histone acetylation as judged by the increased levels of H3K9ac and disruption of tumorspheres formation. Interestingly, ALDH levels were increased in UM-HMC-1 and UM-HMC-3A cell lines, while UM-HMC-2 showed a reduced enzymatic activity. CONCLUSION: Cephaeline has shown anti-cancer properties in all MEC cell lines tested by regulating tumor cells' viability, migration, proliferation, and disrupting the ability of cancer cells to generate tumorspheres.
24
Guidelines for accurate EC50/IC50 estimation
Jeanne L. Sebaugh · Pharmaceutical Statistics · 2010 · 939 citations
Pharmacy, Pharmacology, Toxicology +12
Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer
Kalipso Halkidou, Luke Gaughan, Susan Cook et al. · The Prostate · 2004 · 503 citations
Increased expression of histone deacetylase 2 is found in human gastric cancer
Ji Heon Noh, Jong‐Heun Lee, Jung Woo Eun et al. · Apmis · 2005 · 341 citations